TNF-Related Activation-Induced Cytokine Enhances Leukocyte Adhesiveness: Induction of ICAM-1 and VCAM-1 via TNF Receptor-Associated Factor and Protein Kinase C-Dependent NF-κB Activation in Endothelial Cells

Min, Jeong Ki; Kim, Young Myeong; Kim, Sung Wan; Kwon, Min-Chul; Kong, Young Yun; Hwang, In Koo; Won, Moo Ho; Rho, Jaerang; Kwon, Young Guen

doi:10.4049/jimmunol.175.1.531

Cited by 166 publications

(143 citation statements)

References 77 publications

Supporting

Mentioning

138

Contrasting

Unclassified

Order By: Relevance

“…The role of these cytokines in inflammation, edema formation, fibrosis and tissue remodeling has been well-documented. 24,25 For many years, EPO was considered to be a renally-produced, monolineage-specific hormone which functioned to stimulate the survival, proliferation and differentiation of erythroid cells. 6 However, several recent studies from our laboratory and others have shown that EPO has pleiotropic properties.…”

Section: Discussionmentioning

confidence: 99%

Erythropoietin ameliorates chemotherapy‐induced fibrosis of the lungs in a preclinical murine model

Sigounas

Salleng

Mehlhop

et al. 2008

Intl Journal of Cancer

View full text Add to dashboard Cite

Organ toxicity induced by chemotherapeutic drugs is a serious obstacle in the effective treatment of patients suffering from cancer and autoimmune disease. A strong association exists between pulmonary toxicity, particularly fibrosis, and chemotherapeutic drugs. Attempts have been made to identify compounds capable of suppressing fibrosis. In addition to its erythropoietic activity, erythropoietin (EPO) has been shown to have effects on nonhemopoietic cells. Therefore, we postulated that EPO may exert beneficial effects on lung tissue during chemotherapy. To test our hypothesis, we investigated pulmonary changes caused by bleomycin, a fibrosis‐inducing agent, in animals treated with the drug alone and in combination with EPO. Fibrosis, cellular alterations and structural changes were assayed by blind analysis of the lung sections. A 6‐fold decrease in the number of prominent endothelial cells—suspected to be indicative of cellular activation and inflammatory response—was observed in lung sections derived from mice treated with bleomycin and EPO compared to animals injected with bleomycin alone (p < 0.008). Additionally, there was twice the number of ICAM1‐positive endothelial cells in animals treated with bleomycin alone compared with the number in the bleomycin and EPO‐treated group (p < 0.05). Alveolar mononuclear phagocytic hyperplasia was reduced by as much as 100% in animals treated with bleomycin and EPO compared to animals treated with bleomycin alone (p < 0.03). Finally, a 5‐fold decrease in interstitial fibrosis was observed in lung sections obtained from animals treated with bleomycin and EPO (p < 0.02). We conclude that EPO can ameliorate drug‐induced fibrosis and endothelial damage caused by chemotherapeutic agents. © 2008 Wiley‐Liss, Inc.

show abstract

Section: Discussionmentioning

confidence: 99%

Erythropoietin ameliorates chemotherapy‐induced fibrosis of the lungs in a preclinical murine model

Sigounas

Salleng

Mehlhop

et al. 2008

Intl Journal of Cancer

View full text Add to dashboard Cite

show abstract

“…Moreover, TNF-α also inhibits endothelial nitric oxide (NO)-dependent vasodilatation [56] and activates production of adhesion molecules by endothelial cells [57]. But TNF-α does not have the characteristics of a circulating endocrine signal.…”

Section: Associations May Be the Consequence Of Unconsidered Confoundersmentioning

confidence: 99%

Insulin resistance and the metabolic syndrome—or the pitfalls of epidemiology

Yudkin

2007

Diabetologia

View full text Add to dashboard Cite

The clustering of dyslipidaemia, hypertension and glucose intolerance, predominantly in overweight individuals, has been ascribed many names, including syndrome X and the metabolic syndrome. In Reaven's original description of syndrome X, a central aetiological role was attributed to insulin resistance, and this assumption has remained as the dominant paradigm for the metabolic syndrome. There are a number of conceptual problems in such a model, particularly those arising from observations that several novel markers, including measures of endothelial dysfunction and of low-grade inflammation, are as closely related to insulin resistance as are the classic components of the syndrome. Because it is difficult to envisage how these traits might develop as a consequence of insulin resistance, such observations indicate the need for a new paradigm to explain the mechanisms of association better. It has been proposed that a state of low-grade inflammation, consequent upon the production of adipocytokines, particularly from truncal fat, explains the observed relationships between insulin resistance and endothelial dysfunction better than does a model revolving around insulin resistance. Furthermore, the inflammatory cytokines generated from adipose tissue may influence vessel endothelial function without elevations in circulating concentrations. This review alludes to several problems inherent in the epidemiological method in understanding disease mechanisms. These include crude biological measures, the use of venous systemic fasting samples, imprecision of assays, naive physiological models, simplistic statistical approaches and, without clinical trials, an inability to test causation. Integrated systems biology needs more complex approaches to investigate disease mechanisms, involving cell, organ, whole organism and population studies.

show abstract

“…6A). These data suggest the preferential usage of α4 integrins by lymphocytes for adhesion to bEND3 cells, since TNFα not only up-regulates VCAM-1 but also ICAM-1, a β2 integrin ligand on endothelial cells [27,28]. To determine whether ability to migrate per se is preserved in α4Δ/Δ lymphocytes, we performed migration through an uncoated Transwell insert (trans-well migration) not requiring engagement of α4 integrins.…”

Section: In Vitro Functional Testing Of α4δ/δ Lymphocytesmentioning

confidence: 99%

Unique and redundant roles of α4 and β2 integrins in kinetics of recruitment of lymphoid vs myeloid cell subsets to the inflamed peritoneum revealed by studies of genetically deficient mice

Ulyanova

Priestley

Banerjee

et al. 2007

Experimental Hematology

View full text Add to dashboard Cite

OBJECTIVE-Leukocyte recruitment to inflammatory sites is a prominent feature of acute and chronic inflammation. Instrumental in this process is the coordinated upregulation of leukocyte integrins (among which α4β1 and β2 integrins are major players) and their cognate receptors in inflamed tissues. To avoid the ambiguity of previous short-term antibody-based studies and to allow for long-term observation, we used genetically deficient mice to compare roles of α4 and β2 integrins in leukocyte trafficking.METHODS-Aseptic peritonitis was induced in α4 or β2 integrin-deficient (conditional and conventional knockouts, respectively) and control mice, and recruitment of major leukocyte subsets to the inflamed peritoneum was followed for up to 4 days. RESULTS-Despite normal chemokine levels in the peritoneum and adequate numbers, optimal recruitment of myeloid cells was impaired in both α4-and β2-deficient mice. Furthermore, clearance of recruited neutrophils and macrophages was delayed in these mice. Lymphocyte migration to the peritoneum in the absence of α4 integrins was drastically decreased, both at steady state and during inflammation, a finding consistent with impaired lymphocyte in vitro adhesion and signaling. By contrast, in the absence of β2 integrins, defects in lymphocyte recruitment were only evident when peritonitis was established.CONCLUSIONS-Our data with concurrent use of genetic models of integrin deficiency reveal non-redundant functions of α4 integrins in lymphocyte migration to the peritoneum and further refine specific roles of α4 and β2 integrins concerning trafficking and clearance of other leukocyte subsets at homeostasis and during inflammation.

show abstract

TNF-Related Activation-Induced Cytokine Enhances Leukocyte Adhesiveness: Induction of ICAM-1 and VCAM-1 via TNF Receptor-Associated Factor and Protein Kinase C-Dependent NF-κB Activation in Endothelial Cells

Cited by 166 publications

References 77 publications

Erythropoietin ameliorates chemotherapy‐induced fibrosis of the lungs in a preclinical murine model

Erythropoietin ameliorates chemotherapy‐induced fibrosis of the lungs in a preclinical murine model

Insulin resistance and the metabolic syndrome—or the pitfalls of epidemiology

Unique and redundant roles of α4 and β2 integrins in kinetics of recruitment of lymphoid vs myeloid cell subsets to the inflamed peritoneum revealed by studies of genetically deficient mice

Contact Info

Product

Resources

About